Absci

Performance

About Absci

Absci is a clinical-stage biopharmaceutical company that uses generative biology and computational approaches to accelerate biologics discovery. By combining cell line engineering, synthetic biology, and AI-enabled design processes, Absci aims to shorten the development timeline for therapeutic antibodies and other biologics. The company operates in the United States with a focus on novel biology to create better biologics for patients, often partnering with pharma, tech, and academic collaborators.